NCT04802356
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04802356
Title Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Son Llatzer Palma de Mallorca Balearic Islands 07198 Spain Details
Hospital Universitario Marqués de Valdecilla Santander Cantabria 39008 Spain Details
Hospital Universitario de Salamanca Salamanca Castille and León 37007 Spain Details
Hospital Clínic I Provincial de Barcelona Barcelona Catalonia 08036 Spain Details
Complejo Universitario Hospitalario de Santiago Santiago de Compostela Galicia 15706 Spain Details
Hospital Gregorio Marañon Madrid Madrid 28007 Spain Details
Hospital Universitario 12 de Octubre Madrid Madrid 28041 Spain Details
Hospital de Cabueñes Gijón Principality of Asturias 33394 Spain Details
Hospital Universitario de Canarias San Cristóbal de La Laguna Santa Cruz De Tenerife 38320 Spain Details
Hospital Universitario y Policlínico de la Fe Valencia Valencia 46026 Spain Details
Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas de Gran Canaria Spain Details
Hospital Infanta Leonor Madrid Spain Details
Hospital General Universitario Morales Meseguer Murcia 30008 Spain Details
Hospital Virgen de la Arrixaca Murcia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field